These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
333 related items for PubMed ID: 17540662
1. Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. Gras D, Böcker D, Lunati M, Wellens HJ, Calvert M, Freemantle N, Gervais R, Kappenberger L, Tavazzi L, Erdmann E, Cleland JG, Daubert JC, CARE-HF Study Steering Committee and Investigators. Europace; 2007 Jul; 9(7):516-22. PubMed ID: 17540662 [Abstract] [Full Text] [Related]
2. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy. Bisch L, Da Costa A, Dauphinot V, Romeyer-Bouchard C, Khris L, M'baye A, Isaaz K. Europace; 2010 Aug; 12(8):1141-8. PubMed ID: 20573673 [Abstract] [Full Text] [Related]
3. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure. Herweg B, Ilercil A, Cutro R, Dewhurst R, Krishnan S, Weston M, Barold SS. Am J Cardiol; 2007 Jul 01; 100(1):90-3. PubMed ID: 17599447 [Abstract] [Full Text] [Related]
4. Delayed defibrillation testing in patients implanted with biventricular ICD (CRT-D): a reliable and safe approach. Gasparini M, Galimberti P, Regoli F, Ceriotti C, Bonadies M. J Cardiovasc Electrophysiol; 2005 Dec 01; 16(12):1279-83. PubMed ID: 16403056 [Abstract] [Full Text] [Related]
5. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, DeMarco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M. Circulation; 2007 Jan 16; 115(2):204-12. PubMed ID: 17190867 [Abstract] [Full Text] [Related]
6. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure. Ghali JK, Boehmer J, Feldman AM, Saxon LA, Demarco T, Carson P, Yong P, Galle EG, Leigh J, Ecklund FL, Bristow MR. J Card Fail; 2007 Nov 16; 13(9):769-73. PubMed ID: 17996827 [Abstract] [Full Text] [Related]
7. Two-year performance of a preshaped lead for left ventricular stimulation. Schuchert A, Seidl K, Pfeiffer D, Oltmanns G, Dänschel W, Aydin MA, Paul V. Pacing Clin Electrophysiol; 2004 Dec 16; 27(12):1610-4. PubMed ID: 15613123 [Abstract] [Full Text] [Related]
8. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry). Landolina M, Lunati M, Gasparini M, Santini M, Padeletti L, Achilli A, Bianchi S, Laurenzi F, Curnis A, Vincenti A, Valsecchi S, Denaro A, InSync/InSync ICD Italian Registry Investigators. Am J Cardiol; 2007 Sep 15; 100(6):1007-12. PubMed ID: 17826388 [Abstract] [Full Text] [Related]
9. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure. Haghjoo M, Bonakdar HR, Jorat MV, Fazelifar AF, Alizadeh A, Ojaghi-Haghjghi Z, Esmaielzadeh M, Sadr-Ameli MA. Europace; 2009 Mar 15; 11(3):356-63. PubMed ID: 19136489 [Abstract] [Full Text] [Related]
10. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up. Faran A, Lewicka-Nowak E, Dabrowska-Kugacka A, Kempa M, Tybura S, Szwoch M, Królak T, Raczak G. Kardiol Pol; 2008 Jan 15; 66(1):19-26; discussion 27. PubMed ID: 18266184 [Abstract] [Full Text] [Related]
12. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy. Desai AD, Burke MC, Hong TE, Kim S, Salem Y, Yong PG, Knight BP. J Cardiovasc Electrophysiol; 2006 May 15; 17(5):486-90. PubMed ID: 16684019 [Abstract] [Full Text] [Related]
13. Complications of cardiac resynchronization therapy in patients with congestive heart failure. Niu HX, Hua W, Wang FZ, Zhang S, Chen KP, Chen X. Chin Med J (Engl); 2006 Mar 20; 119(6):449-53. PubMed ID: 16584641 [Abstract] [Full Text] [Related]
15. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience. Sunsaneewitayakul B, Sitthisook S, Sangwatanaroj S, Prechawat S, Songmuang SB. J Med Assoc Thai; 2007 Jul 20; 90(7):1458-66. PubMed ID: 17710992 [Abstract] [Full Text] [Related]
16. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Török T, Linde C, REVERSE Study Group. J Am Coll Cardiol; 2009 Nov 10; 54(20):1837-46. PubMed ID: 19800193 [Abstract] [Full Text] [Related]
17. Long-term retention of cardiac resynchronization therapy. Knight BP, Desai A, Coman J, Faddis M, Yong P. J Am Coll Cardiol; 2004 Jul 07; 44(1):72-7. PubMed ID: 15234410 [Abstract] [Full Text] [Related]
18. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure? Turley AJ, Raja SG, Salhiyyah K, Nagarajan K. Interact Cardiovasc Thorac Surg; 2008 Dec 07; 7(6):1141-6. PubMed ID: 18541605 [Abstract] [Full Text] [Related]